# Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia

> **NCT07473713** · PHASE1 · RECRUITING · sponsor: **Tufts Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Osteopenia

## Interventions

- **DRUG:** veverimer daily
- **DRUG:** veverimer every other day
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07473713
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473713, "Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07473713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*